Trends in interventions to reduce perinatal human immunodeficiency virus type 1 transmission in North Carolina

Pediatric Infectious Disease Journal

Volumn 21, Issue 7, 2002, Pages 664-668

  Fiscus, Susan A ^a,g   Adimora, Adaora A ^a   Funk, Michele L ^b   Schoenbach, Victor J ^b   Tristram, Deborah ^c   Lim, Wilma ^a   Mckinney, Ross ^d   Rupar, David ^e   Woods, Charles ^d,f   Wilfert, Catherine ^d,f  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b IL   (United States)

^c EAST CAROLINA UNIVERSITY   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e CAROLINAS MEDICAL CENTER   (United States)

^f WAKE FOREST SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Antiretroviral therapy; Elective cesarean delivery; North Carolina; Perinatal human immunodeficiency virus transmission

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; DIDANOSINE; LAMIVUDINE; NELFINAVIR; RITONAVIR; SAQUINAVIR; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ARTICLE; CESAREAN SECTION; DISEASE TRANSMISSION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; PREGNANCY; PRENATAL CARE; PRIORITY JOURNAL; UNITED STATES; VAGINAL DELIVERY; VERTICAL TRANSMISSION; CHI SQUARE DISTRIBUTION; COHORT ANALYSIS; CONFIDENCE INTERVAL; DELIVERY; DRUG EFFECT; FOLLOW UP; ISOLATION AND PURIFICATION; MALE; NEWBORN; PERINATAL CARE; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREVALENCE; RETROSPECTIVE STUDY; RISK ASSESSMENT; TREATMENT OUTCOME; VIROLOGY;

ANTI-HIV AGENTS; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; CONFIDENCE INTERVALS; DELIVERY, OBSTETRIC; DISEASE TRANSMISSION, VERTICAL; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV-1; HUMAN; INFANT, NEWBORN; MALE; NORTH CAROLINA; PERINATAL CARE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; PREVALENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TREATMENT OUTCOME; HUMANS;

EID: 0036020182     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200207000-00012     Document Type: Article

References (37)

1. Projection of AIDS and HIV incidence among children born infected with HIV
2. Trends in perinatal transmission of HIV/AIDS in the United States
3. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment: Pediatric AIDS Clinical Trials Group Protocol 076 Study Group
4. Perinatal HIV infection and the effect of zidovudine therapy on transmission in rural and urban counties
5. After AIDS clinical trial 076: The changing pattern of zidovudine use during pregnancy, and the subsequent reduction in the vertical transmission of human immunodeficiency virus in a cohort of infected women and their infants: Women and Infants Transmission Study Group
6. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus
7. Success in implementing public health service guidelines to reduce perinatal transmission of HIV: Louisiana, Michigan, New Jersey, and South Carolina, 1993, 1995, and 1996
8. Ante-partum antiretroviral therapy and pregnancy outcomes in 462 HIV-infected women in 1998-1999
9. Long-term antiretroviral combination therapy including lamivudine in HIV-1 infected women during pregnancy
10. Maternal and infant outcomes with highly active antiretroviral therapy during pregnancy
11. Protease inhibitors: Is preterm delivery a risk?
12. Combination antiretroviral therapy in human immunodeficiency virus-infected pregnant women
13. Multicenter review of protease inhibitors in 89 pregnancies
14. An effective and safe protocol involving zidovudine and cesarean section to reduce vertical transmission of HIV-1 infection
15. Trends in antiretroviral therapies and cesarean-section use for perinatal HIV transmission in New York City
16. Caesarean section and risk of vertical transmission of HIV-1 infection
17. Prevention of vertical HIV transmission: Additive protective effect of elective cesarean section and zidovudine prophylaxis: Swiss Neonatal HIV Study Group
18. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1: A meta-analysis of 15 prospective cohort studies
19. Elective cesarean section vs. vaginal delivery in prevention of vertical HIV-1 transmission: A randomized clinical trial
20. Prophylactic cesarean delivery for the prevention of perinatal human immunodeficiency virus transmission: The case of restraint
21. Maternal complications after caesarean section in HIV infected women
22. Mode of delivery and postpartum morbidity among HIV-infected women: The Women and Infants Transmission Study
23. Complications according to mode of delivery among HIV-infected women with CD4 lymphocyte counts of ≤500/microliter
24. The incidence of complications after cesarean section in 156 HIV-positive women
25. Trends in human immunodeficiency virus (HIV) counseling, testing, and antiretroviral treatment of HIV-infected women and perinatal transmission in North Carolina
26. Perinatal transmission of HIV-1 by pregnant women with RNA virus loads <1000 copies/ml
27. Vertical transmission of multidrug-resistant human immunodeficiency virus type 1 (HIV-1) and continued evolution of drug resistance in an HIV-1-infected infant
28. Cost-effectiveness of elective cesarean delivery in human immunodeficiency virus-infected women
29. Cost-effectiveness of cesarean delivery to prevent mother-to-child transmission of HIV-1
30. The cost-effectiveness of elective cesarean delivery for HIV-infected women with detectable HIV RNA during pregnancy
31. ACOG committee opinion scheduled cesarean delivery and the prevention of vertical transmission of HIV, Number 234, May 2000
32. Increasing trends in cesarean sections in HIV-infected mothers of infants in the Pediatric Spectrum of HIV Disease (PSD) cohort
33. Trends in prevention of perinatal HIV transmission, New York State (NYS), 1997-1999
34. Progress towards elimination of perinatal HIV infection in the United States
35. Increased use of maternal combination antiretroviral therapy and elective cesarean section to reduce perinatal HIV transmission in North Carolina
36. Elective cesarean section may provide additional benefit in conjunction with maternal combination antiretroviral therapy to reduce perinatal HIV transmission